France recognizes Covishield vaccine, relief for Indians and many Africans
France has just recognized the Covishield vaccine in its health pass, a relief because this serum, which is a copy of the AstraZeneca vaccine produced in India, is used in many countries.
Dibyangshu SARKAR AFP
Text by: RFI Follow
2 min
France has just recognized the Covishield vaccine in its "health pass", a relief, because this serum, which is a copy of the AstraZeneca vaccine produced in India, is used in many countries.
Travel in France is therefore easier for Indians and many Africans vaccinated, especially as the quarantine rules are lightened for vaccinated people.
Publicity
Read more
With our correspondent in New Delhi,
Sébastien Farcis
Two weeks after many of its European neighbors, France finally recognizes that Covishield is the equivalent of the AstraZeneca vaccine used in Europe.
And that people who have received this serum will be able to benefit from the same rights of access to public places as those who have been vaccinated in France, with Moderna or Pfizer, among others.
This mainly concerns Indian residents, as well as those of the DRC or Nigeria, countries where Covishield is widely used.
These vaccinated travelers will also no longer need to take a test on departure or arrival in France, or to go into quarantine.
This recognition of Covishield, India's flagship vaccine, represents a symbolic success for New Delhi, which has lobbied all European countries to obtain it.
Covishield is now approved by more than half of EU capitals, even before the European Medicines Agency can comment.
►
Read also:
Covid-19: France introduces new border protection measures
Newsletter
Receive all international news directly in your mailbox
I subscribe
Follow all the international news by downloading the RFI application
google-play-badge_FR
India
France
Vaccines
Coronavirus